Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL) is a distinct and highly treatable subtype of acute myeloid leukemia (AML), characterized by a specific chromosomal...
#targeted therapy
14 articles
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is a slow-progressing hematologic malignancy characterized by the clonal expansion of mature-appearing but immunolo...
Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by the uncontrolled proliferation of myeloid lineage cells—p...
Late-Stage Cancer Patients Don’t Have to Suffer in Silence—What Oncologists Really Advise About Pain Control and Chemotherapy
When a physician delivers a diagnosis of advanced cancer, the weight of those words can feel overwhelming—like a sudden, suffocating pressure on the c...
“Chemo Kills 9 in 10”? Myth Debunked: Oncologists Clarify Which Cancers Don’t Benefit—and May Be Harmed—by Chemotherapy
Chemotherapy remains one of the most widely used and rigorously studied cancer treatments—but persistent myths, particularly the alarming claim that “...
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common histological subtype of lung malignancy, accounting for approximately 85% of all lung cancer cas...
Cancer Patients and Food Restrictions: What’s Actually Off-Limits, According to Oncologists
“Cancer patients must avoid eggs—they’ll cause swelling!” “Honey feeds tumor cells!” These kinds of dietary warnings circulate relentlessly on social ...
Lung Cancer
Lung cancer, a malignant neoplasm originating in the bronchial epithelium or alveolar cells, remains the leading cause of cancer-related mortality wor...
Renal Cell Carcinoma
Renal cell carcinoma (RCC), the most common type of kidney cancer in adults, originates in the proximal convoluted tubules of the renal cortex. Accoun...
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung malignancies and encompasses several histological subtypes—including ade...
HER2-Positive Breast Cancer
HER2-positive breast cancer is an aggressive subtype characterized by overexpression or amplification of the human epidermal growth factor receptor 2 ...
EGFR-Mutated NSCLC
EGFR-mutated non-small cell lung cancer (NSCLC) is a molecularly defined subtype of lung adenocarcinoma characterized by activating mutations in the e...